Credit Suisse’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.7M | Buy |
|
|||||
|
2023
Q4 | $4.09M | Buy |
|
|||||
|
2023
Q3 | $3.85M | Sell |
|
|||||
|
2023
Q2 | $5.09M | Buy |
|
|||||
|
2023
Q1 | $3.83M | Buy |
|
|||||
|
2022
Q4 | $3.23M | Buy |
|
|||||
|
2022
Q3 | $4.64M | Sell |
|
|||||
|
2022
Q2 | $4.34M | Sell |
|
|||||
|
2022
Q1 | $7.25M | Buy |
|
|||||
|
2021
Q4 | $8.4M | Sell |
|
|||||
|
2021
Q3 | $10.7M | Sell |
|
|||||
|
2021
Q2 | $15.9M | Buy |
|
|||||
|
2021
Q1 | $6.47M | Sell |
|
|||||
|
2020
Q4 | $5.56M | Sell |
|
|||||
|
2020
Q3 | $2.55M | Buy |
|
|||||
|
2020
Q2 | $2.26M | Buy |
|
|||||
|
2020
Q1 | $739K | Buy |
|
|||||
|
2019
Q4 | $595K | Buy |
|
|||||
|
2019
Q3 | $335K | Sell |
|
|||||
|
2019
Q2 | $428K | Buy |
|
|||||
|
2019
Q1 | $341K | Sell |
|
|||||
|
2018
Q4 | $363K | Buy |
|
|||||
|
2018
Q3 | $721K | Sell |
|
|||||
|
2018
Q2 | $967K | Buy |
|
|||||
|
2018
Q1 | $638K | Buy |
|
|||||
|
2017
Q4 | $498K | Buy |
|
|||||
|
2017
Q3 | $585K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $162K | Sell |
|
|||||
|
2016
Q3 | $245K | Buy |
|